https://www.facebook.com/share/p/1FMtui9omB/

Israel is widely recognized as a global leader in bioconvergence, a multidisciplinary field that merges biology with engineering, AI, nanotechnology, and data science.  The Israel Innovation Authority spearheads this effort through a National Bioconvergence Program launched in 2020, aiming to transform the country into a primary hub for this emerging industry. https://search.brave.com/search?q=Israel+leading+the+global+bioconvergence+revolution&source=android&conversation=099b14a000f28b5fc0e429f1e2201d438471 . Canada and Israel are both actively investing in the biodigital convergence, a field defined as the merging of biological and digital technologies.  Policy Horizons Canada, a federal strategic foresight organization, leads national efforts to explore the cross-cutting policy implications of this convergence, which includes three key pillars: data, genomics, and critical systems.

Israel positions itself as a global bioconvergence hub through the Israel Innovation Authority, which funds startups blending biology with AI, nano-engineering, and robotics.  Both nations are part of a broader global trend, including the EU, US, and China https://search.brave.com/search?q=canada+biodigital+convergence+Israel&source=android&conversation=099ba18ea6e0e1d816db047a9ac6c799d17b . Bioconvergence in the United States refers to the accelerating fusion of biology with artificial intelligence (AI), nanotechnology, engineering, and digital infrastructure, creating a transformative era for healthcare, manufacturing, and national security.  This interdisciplinary approach is redefining how biological capabilities are discovered and developed, moving beyond traditional biotechnology to enable precise, personalized, and scalable innovations. https://search.brave.com/search?q=usa+bioconvergence+revolution&source=android&conversation=099b95365e5446c328ade762ad0e4f8ff5e1